Penumbra Ownership

PEN Stock  USD 230.38  0.28  0.12%   
Penumbra owns a total of 38.73 Million outstanding shares. The majority of Penumbra outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Penumbra to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Penumbra. Please pay attention to any change in the institutional holdings of Penumbra as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2014-03-31
Previous Quarter
39.3 M
Current Value
39.2 M
Avarage Shares Outstanding
33.7 M
Quarterly Volatility
M
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as Penumbra in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Penumbra, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Penumbra. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
To learn how to invest in Penumbra Stock, please use our How to Invest in Penumbra guide.

Penumbra Stock Ownership Analysis

About 92.0% of the company shares are owned by institutional investors. The company has Price/Earnings (P/E) ratio of 191.13. Penumbra had not issued any dividends in recent years. The entity had 10:1 split on the 16th of November 2014. Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California. Penumbra operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 3800 people. To find out more about Penumbra contact Adam Elsesser at 510 748 3200 or learn more at https://www.penumbrainc.com.
Besides selling stocks to institutional investors, Penumbra also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Penumbra's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Penumbra's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Penumbra Quarterly Liabilities And Stockholders Equity

1.59 Billion

Penumbra Insider Trades History

Roughly 4.0% of Penumbra are currently held by insiders. Unlike Penumbra's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Penumbra's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Penumbra's insider trades
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Penumbra Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Penumbra is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Penumbra backward and forwards among themselves. Penumbra's institutional investor refers to the entity that pools money to purchase Penumbra's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
T. Rowe Price Investment Management,inc.2025-03-31
633.6 K
Clearbridge Advisors, Llc2025-03-31
586.8 K
Congress Asset Management Company, Llp2025-03-31
546.3 K
Capital World Investors2025-03-31
543.8 K
Hhg Plc2025-03-31
541.3 K
Holocene Advisors, Lp2025-03-31
402.3 K
Morgan Stanley - Brokerage Accounts2025-03-31
372.7 K
Allspring Global Investments Holdings, Llc2025-03-31
321 K
Northern Trust Corp2025-03-31
316 K
Fmr Inc2025-03-31
5.8 M
Blackrock Inc2025-03-31
4.1 M
Note, although Penumbra's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Penumbra Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Penumbra insiders, such as employees or executives, is commonly permitted as long as it does not rely on Penumbra's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Penumbra insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Penumbra Outstanding Bonds

Penumbra issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Penumbra uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Penumbra bonds can be classified according to their maturity, which is the date when Penumbra has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Penumbra Corporate Filings

F4
11th of July 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
30th of May 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
16th of April 2025
Other Reports
ViewVerify
4th of April 2025
Other Reports
ViewVerify

Pair Trading with Penumbra

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Penumbra position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Penumbra will appreciate offsetting losses from the drop in the long position's value.

Moving together with Penumbra Stock

  0.64CI Cigna CorpPairCorr

Moving against Penumbra Stock

  0.79VEEV Veeva Systems ClassPairCorr
  0.76DH Definitive HealthcarePairCorr
  0.69VNRX VolitionrxPairCorr
  0.67OM Outset MedicalPairCorr
  0.5LH Laboratory Earnings Call This WeekPairCorr
The ability to find closely correlated positions to Penumbra could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Penumbra when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Penumbra - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Penumbra to buy it.
The correlation of Penumbra is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Penumbra moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Penumbra moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Penumbra can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Penumbra offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Penumbra's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Penumbra Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Penumbra Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Penumbra. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
To learn how to invest in Penumbra Stock, please use our How to Invest in Penumbra guide.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Penumbra. If investors know Penumbra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Penumbra listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
2.571
Earnings Share
1.08
Revenue Per Share
32.131
Quarterly Revenue Growth
0.163
Return On Assets
0.0582
The market value of Penumbra is measured differently than its book value, which is the value of Penumbra that is recorded on the company's balance sheet. Investors also form their own opinion of Penumbra's value that differs from its market value or its book value, called intrinsic value, which is Penumbra's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Penumbra's market value can be influenced by many factors that don't directly affect Penumbra's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Penumbra's value and its price as these two are different measures arrived at by different means. Investors typically determine if Penumbra is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Penumbra's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.